Mood Temperaments in Patients With Diabetes Mellitus Authors: Minoo Heidari Almasi, Tara Heidarialmasi, Parisa Delkash, Hamideh Moradi Shahrbabak, Shideh Ariana, Roya Vaziri‐Harami Published: 2025 ABSTRACT ABSTRACTBackground and AimsTemperamental traits are stable, biologically based personality characteristics that shape an individual′s emotional and behavioral responses. While certain traits, in their extreme expressions, may predispose individuals to mood disorders and diabetes‐related distress, others may confer resilience and protective benefits. Evaluating the prevalence and patterns of these traits in diabetic patients is therefore essential for a holistic understanding of their psychological profile. This study aimed to assess and compare temperamental characteristics between diabetic patients and healthy individuals.MethodsThis cross‐sectional study included diabetic patients referred to the internal medicine and psychiatry clinics at Shahid Beheshti University of Medical Sciences. Temperamental traits were assessed in both patients and a healthy control group using the shortened Persian version of the TEMPS‐A, a self‐report questionnaire designed in 2005 to evaluate anxious, depressive, irritable, cyclothymic, and hyperthymic temperaments. The Persian version's validity and reliability had been confirmed, and the study assessed these traits in diabetic patients using this validated tool.ResultsA total of 62 participants were included, with a mean age of 46.33 ± 14.87 years. The case group was significantly older (p = 0.0001) and had a higher body mass index (BMI) (p = 0.002) than the control group. The case group showed a significantly higher dysthymic temperament score (p = 0.040). No significant differences were found in irritable, anxious, cyclothymic, or hyperthymic temperament, though hyperthymic temperament scores were higher in men in the case group (p = 0.044). Age was not significantly associated with temperamental traits.ConclusionsThis study highlights the importance of assessing affective temperaments, particularly depressive (dysthymic) temperament, in the management of diabetes. The presence of this temperamental trait suggests a higher vulnerability for developing mood disorders. Therefore, routine psychological screening for such predispositions is essential for identifying at‐risk patients and implementing early interventions to improve overall treatment outcomes and quality of life. Abbreviations body mass index Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition gestational diabetes mellitus hypothalamic–pituitary–adrenal Minnesota Multiphasic Personality Inventory Structured Clinical Interview for DSM‐5 type 2 diabetes mellitus Introduction Diabetes and depression are globally prevalent, interrelated conditions. Depression, occurring nearly twice as frequently in individuals with diabetes, worsens these issues by promoting poor lifestyle choices [1]. Type 2 diabetes mellitus (T2DM), projected to affect 366 million people by 2030, is linked to increased risks of complications and higher healthcare costs [2]. Depressive temperament, occurring nearly twice as frequently in individuals with diabetes, worsens these issues by promoting poor lifestyle choices, escalating complications, and reducing productivity [3]. Emotional distress in diabetes further complicates self‐management, making regular screening for depressive temperament essential. Despite its high prevalence, depressive temperament often goes identify a predisposition and untreated in diabetic individuals, highlighting the need for tailored interventions [4]. Affective temperament, a concept introduced by Hagop Akiskal, describes stable, biologically influenced personality traits that represent the underlying substrate of an individual′s emotional reactivity [5]. It is crucial to emphasize that these traits are not pathological in themselves; rather, they represent a spectrum of normal personality variants. Their impact is context‐dependent. While certain traits, particularly in their pronounced expressions, can predispose individuals to mood disorders, others can be highly adaptive and protective. For example, a hyperthymic temperament is often associated with optimism, high energy, and resilience, which may be beneficial in managing a chronic disease like diabetes. The TEMPS‐A tool, developed to assess these temperamental traits, evaluates anxious, depressive, irritable, cyclothymic, and hyperthymic dimensions [6]. It also identifies risks for pregnancy complications and connects affective temperament to dopaminergic genes, particularly in obesity‐related depressive temperament, aiding in identifying individuals at greater risk of depressive symptoms and diabetes‐related distress [6]. In Iran, diabetes is an increasingly significant health concern, often accompanied by comorbidities [7]. T2DM impacts both physical and mental health, with depressive temperament being a common comorbidity. Research indicates that diabetes‐focused treatment can reduce depressive symptoms, and diabetes‐specific psychological interventions can enhance self‐management in depressed patients [8]. Routine screening for depressive temperament in diabetic patients is emphasized to bridge the treatment gap and improve outcomes, with future studies needed to explore tailored psychopharmacological and psychological interventions [9]. Additionally, antidiabetic drugs like metformin have shown efficacy in treating depressive temperament, further underscoring the strong bidirectional link between diabetes and depressive temperament [10, 11]. Previous studies have used tools like the Minnesota Multiphasic Personality Inventory (MMPI) to examine temperamental traits [10]. However, these tools focus primarily on psychiatric symptoms, such as depressive temperament, and overlook broader personality dimensions. To address this, Akiskal and colleagues developed the TEMPS‐I interview, applying Kraepelinian temperaments to four distinct temperamental dimensions [12]. In 1998, a new dimension, generalized anxiety temperament, was added to expand the tool′s applicability [13]. This study was conducted at Imam Hossein Hospital, a major tertiary care center affiliated with Shahid Beheshti University of Medical Sciences in Tehran. The hospital was selected for its diverse diabetic patient population, adequate data collection infrastructure, and established internal medicine and psychiatry clinics, making it suitable for the study's needs. Given the availability of required data, this research is feasible and offers valuable insights into the interplay between affective temperament and diabetes‐related distress. Materials and Methods Study Design This study is a cross‐sectional design aimed at evaluating diabetic patients referred to Hospital. The data collection methods included observation, questionnaires, and interviews. Study Population The study population consisted of patients with T2DM visiting the Internal Medicine Department at Imam Hossein Hospital over a 3‐month period. Participants were selected through convenience sampling, including all T2DM patients who attended the outpatient internal medicine clinic during this time. Informed consent was obtained from all participants following an explanation of the study objectives and procedures. The healthy control group was recruited concurrently via convenience sampling from hospital staff and accompanying visitors. Controls were matched for age and gender where possible and had no history of systemic diseases. Inclusion Criteria Case group (T2DM patients): Diagnosis of T2DM confirmed by an internal medicine specialist; minimum literacy level (ability to read and write); willingness to participate.Healthy control group: Minimum literacy level; willingness to participate; no history of systemic diseases. Case group (T2DM patients): Diagnosis of T2DM confirmed by an internal medicine specialist; minimum literacy level (ability to read and write); willingness to participate. Case group (T2DM patients): Diagnosis of T2DM confirmed by an internal medicine specialist; minimum literacy level (ability to read and write); willingness to participate. Healthy control group: Minimum literacy level; willingness to participate; no history of systemic diseases. Healthy control group: Minimum literacy level; willingness to participate; no history of systemic diseases. Exclusion Criteria Participants unwilling to cooperate.Participants with a history of major psychiatric disorders such as bipolar disorder, schizophrenia, schizoaffective disorder, personality disorders, major depressive disorder, anxiety disorders, or substance abuse (as assessed by a psychiatrist using the Structured Clinical Interview (SCID‐5)). Participants unwilling to cooperate. Participants unwilling to cooperate. Participants with a history of major psychiatric disorders such as bipolar disorder, schizophrenia, schizoaffective disorder, personality disorders, major depressive disorder, anxiety disorders, or substance abuse (as assessed by a psychiatrist using the Structured Clinical Interview (SCID‐5)). Participants with a history of major psychiatric disorders such as bipolar disorder, schizophrenia, schizoaffective disorder, personality disorders, major depressive disorder, anxiety disorders, or substance abuse (as assessed by a psychiatrist using the Structured Clinical Interview (SCID‐5)). Data Collection The study procedure began with participant recruitment, conducted over a 3‐month period at Imam Hossein Hospital. Diabetic patients were identified during routine visits to the internal medicine and psychiatry clinics, where a research assistant screened for eligibility based on inclusion and exclusion criteria. Healthy controls were recruited from hospital staff and visitors without systemic diseases, matched for age and gender where possible. Eligible participants were invited to participate, and those who consented underwent an initial interview to explain the study′s purpose, confidentiality, and voluntary nature. Following the interview, participants were evaluated by a psychiatrist using the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM‐5) criteria and the semi‐structured for DSM‐5 (SCID‐5) questionnaire to rule out major psychiatric disorders. Those meeting the inclusion criteria proceeded to the questionnaire phase. The TEMPS‐A questionnaire, originally developed in English, was translated into Persian by a team consisting of two bilingual psychologists and a linguist from Shahid Beheshti University of Medical Sciences. The translation process included forward translation by the psychologists, followed by back‐translation into English by the linguist to ensure accuracy and consistency with the original content. Discrepancies were resolved through discussion and expert review. The Persian version, validated by Khalili and colleagues, consists of 39 items rated on a 5‐point Likert scale (from not at all to very much) covering five temperamental domains (dysthymic, cyclothymic, hyperthymic, irritable, and anxious). It was administered in a supervised session, with a trained research assistant available to assist those with limited literacy by reading questions aloud and recording responses. The session lasted ~20–30 min, and participants were encouraged to ask questions for clarification. A pilot test with ten diabetic patients was conducted prior to full implementation to ensure clarity and cultural appropriateness, with adjustments made based on feedback. Reliability and validity were confirmed by Khalili et al. (Cronbach's α = 0.85) [14]. Additionally, demographic data, including age, gender, education level, and socioeconomic status, were collected through a separate self‐report questionnaire administered during the same session. Sample Size Calculation The sample size was determined using a standard formula, considering a confidence level of 95% and an acceptable margin of error of 14%. Based on the number of diabetic patients attending Shahid Beheshti University of Medical Sciences clinics over 1 year, the required sample size was calculated to be 31 individuals per group. n=N⋅t2⋅p(1−p)d2+t2⋅p(1−p). Data Analysis Data were analyzed using SPSS software version 22. Quantitative data are presented as mean ± standard deviation (SD), and qualitative data as frequencies and percentages. The primary analysis was the comparison of temperamental traits between the case and control groups using independent samples T‐tests (or Mann–Whitney U tests if normality assumptions were violated, assessed by the Shapiro–Wilk test). Comparisons of demographic variables between groups were conducted using independent T‐tests for continuous variables and χ 2 tests for categorical variables. Exploratory analyses of temperament by demographic factors within groups were conducted but are acknowledged to be underpowered; their results are interpreted with caution as hypothesis‐generating only. A significance level of p < 0.05 was used, with Bonferroni correction for multiple comparisons where appropriate. The study adheres to the STROCSS criteria. Ethical Considerations This study was conducted in accordance with the principles of the Declaration of Helsinki and received ethical approval from the Shahid Beheshti University of Medical Sciences ethical committee (IR.SBMU.RETECH.REC.1403.322). Written informed consent was obtained from all participants after a detailed explanation of the study′s purpose, procedures, potential risks, and benefits. Participants were informed of their right to withdraw at any time without consequences. Confidentiality was maintained through de‐identification of data and secure storage, with access restricted to authorized research personnel. Participants were also provided with contact information for the research team and a counselor for support if any psychological distress arose during the study. Results Description of Demographic and Clinical Information of Patients in Two Groups The study included 62 participants across case and control groups. The mean age was 46.33 ± 14.87 years, with the case group (53.71 ± 13.80 years) significantly older than the control group (36 ± 9.12 years) (p = 0.0001). Participants were 64.5% female and 35.5% male, with no significant gender difference (p = 0.822). Marital status showed 75.8% married and 24.2% single, with no significant difference (p = 0.380). An analysis of participants' households revealed that the control group had a significantly lower proportion of households with children under 2 years of age (p = 0.004) (Table 1). BMI was higher in the case group (29.04 ± 0.94 kg/m2) than the control group (25.76 ± 3.41 kg/m2) (p = 0.002), and the mean diabetes duration in the case group was 8.98 ± 8.67 years (Table 2 and Figure 1). Table 1Description of patients' demographic information.VariablesControl (n = 27)Case (n = 35)Total (n = 62) p Age (yr)—36 ± 9.1253.71 ± 13.8046.33 ± 14.87< 0.0001Age (yr)≤ 4624 (88.9)12 (34.3)36 (58.1)< 0.0001> 463 (11.1)23 (65.7)26 (41.9)SexMale10 (37)12 (34.3)22 (35.5)0.822Female17 (63)23 (65.7)40 (64.5)Marital statusSingle8 (29.6)7 (20)15 (24.2)0.380Married19 (70.4)28 (80)47 (75.8)Number of children< 218 (94.7)14 (50)32 (68.1)0.0044, 31 (5.3)12 (42.9)13 (27.7)> 40 (0)2 (7.1)2 (4.3)BMI (Kg/m2)25.76 ± 3.4129.04 ± 3.9427.52 ± 4.030.002Duration of diabetes (years)——8.98 ± 8.678.98 ± 8.67—John Wiley & Sons, Ltd. Description of patients' demographic information. Table 2Comparison of temperamental traits (TEMPS‐A scores) between case and control groups.Temperamental traitTotal (n = 62) mean ± SDCase group (n = 35) mean ± SDControl group (n = 27) mean ± SD p Irritable0.23 ± 0.220.23 ± 0.240.24 ± 0.200.493Anxious0.30 ± 0.350.31 ± 0.390.29 ± 0.300.228Depressive (dysthymic)0.28 ± 0.270.31 ± 0.330.21 ± 0.190.040Cyclothymic0.24 ± 0.470.25 ± 0.520.22 ± 0.410.100Hyperthymic0.24 ± 0.570.22 ± 0.550.26 ± 0.610.335John Wiley & Sons, Ltd. Comparison of temperamental traits (TEMPS‐A scores) between case and control groups. Depressive mood characteristics in patients in the case and control groups. Description and Comparison of Temperamental Traits in Patients of Two Groups Table 2 presents temperamental traits, including irritability, anxiety, dysthymia, cyclothymia, and hyperthymic. The case group showed a significantly higher dysthymic temperament score (0.31 ± 0.33) than the control group (0.21 ± 0.19) (p = 0.040). No significant differences were found in irritability (p = 0.493), anxiety (p = 0.228), cyclothymia (p = 0.100), or hyperthymic (p = 0.335). The Relationship Between Temperamental Traits, Age, and Gender in Patients of Two Groups In the case group, the mean hyperthymic score was higher in men (0.24 ± 0.65) than in women (0.20 ± 0.49), with a significant difference (p = 0.044) (Table 3). No significant differences in other temperament traits were observed between groups (p > 0.05). Age showed no significant association with temperament traits in either group (p > 0.05) (Table 4). Table 3Comparison of TEMPS‐A temperament scores by sex in the total sample and by group.TemperamentSexTotal (n = 62) mean ± SD p Case (n = 35) mean ± SD p * Control (n = 27) mean ± SD p * IrritableMale0.29 ± 0.270.2000.28 ± 0.320.1580.30 ± 0.220.764Female0.20 ± 0.200.20 ± 0.200.21 ± 0.19AnxiousMale0.34 ± 0.310.4580.35 ± 0.390.9830.32 ± 0.220.276Female0.28 ± 0.370.30 ± 0.390.26 ± 0.34DepressiveMale0.32 ± 0.240.6100.36 ± 0.350.7570.20 ± 0.110.151Female0.25 ± 0.280.28 ± 0.320.20 ± 0.23CyclothymicMale0.25 ± 0.470.9840.24 ± 0.580.2740.19 ± 0.340.202Female0.24 ± 0.470.25 ± 0.480.23 ± 0.46HyperthymicMale0.26 ± 0.640.0790.24 ± 0.650.0440.29 ± 0.640.648Female0.23 ± 0.530.20 ± 0.49* p value for comparison between sexes within each group (e.g., male vs. female within cases).John Wiley & Sons, Ltd. Comparison of TEMPS‐A temperament scores by sex in the total sample and by group. p value for comparison between sexes within each group (e.g., male vs. female within cases). Table 4Comparison of TEMPS‐A temperament scores by age group (≤ 46 vs. > 46) in the total sample and by group.TemperamentAge groupTotal (n = 62) mean ± SD p Case (n = 35) mean ± SD p * Control (n = 27) mean ± SD p * Irritable> 460.26 ± 0.250.3500.27 ± 0.310.2400.25 ± 0.220.277≤ 460.20 ± 0.190.21 ± 0.210.10 ± 0.10Anxious> 460.32 ± 0.360.8320.38 ± 0.420.7260.29 ± 0.330.124≤ 460.28 ± 0.340.28 ± 0.370.09 ± 0.10Depressive> 460.27 ± 0.270.9140.24 ± 0.380.5530.21 ± 0.210.095≤ 460.29 ± 0.270.29 ± 0.310.10 ± 0.05Cyclothymic> 460.25 ± 0.470.9340.27 ± 0.550.5340.22 ± 0.430.187≤ 460.24 ± 0.470.24 ± 0.500.09 ± 0.25Hyperthymic> 460.25 ± 0.600.3000.23 ± 0.560.8020.27 ± 0.620.438≤ 460.23 ± 0.530.23 ± 0.540.25 ± 0.50* p value for comparison between age groups within each group (e.g., > 46 vs. ≤ 46 within cases).John Wiley & Sons, Ltd. Comparison of TEMPS‐A temperament scores by age group (≤ 46 vs. > 46) in the total sample and by group. p value for comparison between age groups within each group (e.g., > 46 vs. ≤ 46 within cases). Discussion This study identifies the temperamental traits of diabetic patients, providing insights for evaluating treatment responses in those referred to internal medicine and psychiatric clinics. Diabetes, with rising prevalence in the world, is often linked to depressive temperament and distress, yet many cases go identify a predisposition. Routine screening and diabetes‐specific psychological interventions can improve self‐management and reduce depressive temperament symptoms [15, 16]. This study found the case group was older (p = 0.0001) with higher BMI (p = 0.002) and a greater depressive temperament trait (p = 0.040). The hyperthymic temperament trait was significantly higher in men (p = 0.044), while other temperament traits showed no significant correlation with age or most demographics [17]. The significantly higher BMI in our diabetic cohort is a critical finding that merits further discussion. This aligns with the well‐established comorbidity between type 2 diabetes and obesity. More importantly, it invites consideration of a shared pathophysiological pathway between metabolic dysregulation and psychiatric vulnerability. As the reviewer rightly points out, evidence suggests that obesity and elevated BMI are linked to an increased risk of bipolar mood spectrum features [18]. While our study measured temperamental predispositions rather than clinical assess traits, the presence of a higher depressive temperament in a group with elevated BMI may point to a common underlying substrate, such as chronic inflammation, dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis, or insulin resistance affecting neuroplasticity. This result suggests that the elevated BMI in our diabetic cohort is not merely a comorbidity but may actively contribute to a broader psychological risk profile. It reinforces the concept of a metabolic‐mood spectrum, where metabolic parameters like BMI and glucoregulation are intertwined with affective states and temperamental predispositions. This interplay warrants further investigation to elucidate the directional relationships and underlying mechanisms linking metabolic factors with mood spectrum disorders and traits [18]. A 2019 review article stated that although a significant number of diabetic patients suffer from depressive temperament or diabetes‐related distress, most remain identify a predisposition and untreated [19]. This treatment gap highlights the need for routine screening for depressive temperament and distress in diabetic patients. Studies have confirmed that diabetes‐focused treatment may reduce depressive symptoms [20], and diabetes‐specific psychological interventions could improve self‐management in depressed diabetic patients [21]. The effectiveness of tailored psychopharmacological and psychological interventions in treating depressive temperament among diabetic patients should be further investigated in future studies [22]. Gouda and colleagues demonstrate that poor dietary habits are significantly linked to poor blood sugar control and body weight, highlighting the role of lifestyle choices in metabolic health. Our study, on the other hand, emphasizes the importance of monitoring temperamental traits, particularly depressive temperament, as predispositions in diabetes patients. Both studies underscore critical factors in diabetes management. Together, these findings suggest that effective diabetes treatment requires both psychological care and dietary improvements [23]. Lesiewska and colleagues examine the role of affective temperament in blood sugar control, finding that individuals with more pronounced expressions of temperament, depressive temperament, and anxiety may need additional medical support for better self‐management. They highlight the TEMPS‐A tool as a simple and effective method to identify patients with pronounced temperamental traits who may benefit from psychological care; such targeted care could, in turn, improve adherence in obese patients with carbohydrate metabolism disorders, emphasizing the potential impact of temperament on diabetes outcomes. Our study similarly underscores the higher prevalence of depressive temperament in diabetic patients, suggesting a potential predisposition to mood disorders and the need for mental health interventions. Both studies emphasize the critical role of psychological factors in diabetes management [24]. A 2010 review found that individuals with type 2 diabetes are 24% more likely to develop depressive temperament compared to those without diabetes, though the underlying mechanisms remain unclear and require further research. Both our study and Nouwen and colleagues highlight the link between diabetes and psychological factors. Our study finds higher levels of depressive temperament in diabetics, suggesting a potential predisposition to mood disorders, while Nouwen and colleagues reveal an increased long‐term risk of depressive temperament in diabetic individuals. These findings underscore the importance of routine psychological screening and targeted interventions for diabetic patients [25]. Rezaei Ardani et al. identified anxiety and irritability as significant factors in gestational diabetes mellitus (GDM), with anxiety being a key predictor of impaired glucose metabolism [26]. It is important to note that our study did not specifically distinguish between diabetes types; however, given the demographic profile of our cohort (older age, higher BMI), it is likely predominantly composed of T2DM patients. Within this likely T2DM context, we found higher depressive temperament traits. Other research has highlighted links between emotional temperaments and GDM [26]. While these findings across different diabetes subtypes collectively emphasize the psychological impact of diabetes, they also underscore that the specific manifestations may vary. This highlights the critical need for future research to explicitly tailor investigations and interventions to specific diabetes subtypes [18]. Individuals with type 2 diabetes often experience greater psychological distress and exhibit distinct personality traits compared to those without the condition [19, 20]. Van Dooren and colleagues highlight the mental health challenges and personality changes in diabetic patients, while our study focuses on temperament traits like depressive temperament and demographic factors. Longitudinal analyses in the Maastricht study aim to clarify the biological and behavioral mechanisms linking psychological distress to complications and mortality in type 2 diabetes. Both studies emphasize the psychological burden of diabetes and underscore the need for routine mental health screening and targeted interventions to improve diabetes management [27]. McKellar and colleagues highlight how clinical depressive symptoms impair adherence to self‐care. Our study complements this by identifying a higher prevalence of underlying depressive temperamental traits in diabetic patients. This finding points to a stable predisposition that increases vulnerability to a range of affective disorders and underscores the need for regular mental health screening. Such screening would aim to identify those at risk, enabling early intervention before the potential development of full‐blown clinical disorders. Both studies emphasize the strong link between mental health and diabetes, supporting the importance of integrated psychological and medical care to enhance outcomes for diabetic patients [28, 29]. This study has several limitations that should be considered when interpreting the results. First, it was a single‐center study, which limits the generalizability of our findings. Second, and critically, the selection of the control group represents a significant limitation. Our control participants were recruited from hospital staff via convenience sampling. This nonrandom method likely resulted in a sample that is not representative of the general population. This group may possess unique occupational, health‐conscious, or socioeconomic characteristics that could bias the comparisons of temperamental traits (e.g., they might have better overall health literacy or different stress profiles). Third, as previously noted, the lack of specification regarding diabetes type (e.g., types 1 and 2) in our inclusion criteria limits the precision of our conclusions. Therefore, future research should conduct this study with a larger, multicenter sample, utilize a population‐based control group, explicitly stratify by diabetes type, and examine more parameters. Conclusion This study identified a significantly higher prevalence of depressive (dysthymic) temperamental traits in patients with type 2 diabetes compared to healthy controls. This finding does not indicate a diagnosis of the mood disorder dysthymia but rather points to a stable personality predisposition that confers a greater risk for developing clinical depressive temperament and diabetes‐related distress. Therefore, our results underscore the critical need for integrating routine psychological screening, using tools like the TEMPS‐A, into standard diabetes care. Identifying patients with these temperamental vulnerabilities allows for early, tailored interventions—such as cognitive‐behavioral therapy, mindfulness training, or supportive counseling—that can mitigate this risk. Ultimately, a holistic treatment approach that addresses both the physiological and psychological predispositions of patients is essential for improving self‐management, adherence, and overall quality of life in diabetes management. Author Contributions Minoo Heidari Almasi: conceptualization, investigation, funding acquisition, writing – original draft, project administration, formal analysis, software, methodology, validation. Tara Heidarialmasi: writing – original draft, writing – review and editing, project administration, resources, supervision, data curation. Parisa Delkash: project administration, formal analysis, methodology, validation, visualization, conceptualization, supervision. Hamideh Moradi Shahrbabak: resources, data curation, supervision, project administration, writing – review and editing, writing – original draft, funding acquisition. Shideh Ariana: methodology, validation, visualization, writing – review and editing, software, formal analysis. Roya Vaziri‐Harami: visualization, validation, methodology, conceptualization, investigation, funding acquisition, software, project administration. All authors have read and approved the final version of the manuscript. Minoo Heidari Almasi had full access to all of the data in this study and takes complete responsibility for the integrity of the data and the accuracy of the data analysis. Disclosure The lead author Minoo Heidari Almasi affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained. Ethics Statement This study was conducted in accordance with the principles of the Declaration of Helsinki and received ethical approval from the Shahid Beheshti University of Medical Sciences Ethical Committee (IR.SBMU.RETECH.REC.1403.322). Consent Written informed consent was obtained from all participants after a detailed explanation of the study′s purpose, procedures, potential risks, and benefits. Conflicts of Interest The authors declare no conflicts of interest.